Literature DB >> 17142343

Increased expression of SERCA in the hearts of transgenic mice results in increased oxidation of glucose.

Darrell D Belke1, Eric Swanson, Jorge Suarez, Brian T Scott, Antine E Stenbit, Wolfgang H Dillmann.   

Abstract

While several transgenic mouse models exhibit improved contractile characteristics in the heart, less is known about how these changes influence energy metabolism, specifically the balance between carbohydrate and fatty acid oxidation. In the present study we examine glucose and fatty acid oxidation in transgenic mice, generated to overexpress sarco(endo)plasmic reticulum calcium-ATPase (SERCA), which have an enhanced contractile phenotype. Energy substrate metabolism was measured in isolated working hearts using radiolabeled glucose and palmitate. We also examined oxygen consumption to see whether SERCA overexpression is associated with increased oxygen utilization. Since SERCA is important in calcium handling within the cardiac myocyte, we examined cytosolic calcium transients in isolated myocytes using indo-1, and mitochondrial calcium levels using pericam, an adenovirally expressed, mitochondrially targeted ratiometric calcium indicator. Oxygen consumption did not differ between wild-type and SERCA groups; however, we were able to show an increased utilization of glucose for oxidative metabolism and a corresponding decreased utilization of fatty acids in the SERCA group. Cytosolic calcium transients were increased in myocytes isolated from SERCA mice, and they show a faster rate of decay of the calcium transient. With these observations we noted increased levels of mitochondrial calcium in the SERCA group, which was associated with an increase in the active form of the pyruvate dehydrogenase complex. Since an increase in mitochondrial calcium levels leads to activation of the pyruvate dehydrogenase complex (the rate-limiting step for carbohydrate oxidation), the increased glucose utilization observed in isolated perfused hearts in the SERCA group may reflect a higher level of mitochondrial calcium.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17142343     DOI: 10.1152/ajpheart.00884.2006

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  18 in total

Review 1.  Measuring mitochondrial function in intact cardiac myocytes.

Authors:  Elena N Dedkova; Lothar A Blatter
Journal:  J Mol Cell Cardiol       Date:  2011-09-22       Impact factor: 5.000

2.  Altered ventricular torsion and transmural patterns of myocyte relaxation precede heart failure in aging F344 rats.

Authors:  Stuart G Campbell; Premi Haynes; W Kelsey Snapp; Kristofer E Nava; Kenneth S Campbell
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-06-21       Impact factor: 4.733

3.  Restoring mitochondrial calcium uniporter expression in diabetic mouse heart improves mitochondrial calcium handling and cardiac function.

Authors:  Jorge Suarez; Federico Cividini; Brian T Scott; Kim Lehmann; Julieta Diaz-Juarez; Tanja Diemer; Anzhi Dai; Jorge A Suarez; Mohit Jain; Wolfgang H Dillmann
Journal:  J Biol Chem       Date:  2018-04-06       Impact factor: 5.157

4.  Thyroid hormone treatment to mend a broken heart.

Authors:  Irwin Klein; Sara Danzi
Journal:  J Clin Endocrinol Metab       Date:  2008-04       Impact factor: 5.958

5.  Integrins protect cardiomyocytes from ischemia/reperfusion injury.

Authors:  Hideshi Okada; N Chin Lai; Yoshitaka Kawaraguchi; Peter Liao; Jeffrey Copps; Yasuo Sugano; Sunaho Okada-Maeda; Indroneal Banerjee; Jan M Schilling; Alexandre R Gingras; Elizabeth K Asfaw; Jorge Suarez; Seok-Min Kang; Guy A Perkins; Carol G Au; Sharon Israeli-Rosenberg; Ana Maria Manso; Zheng Liu; Derek J Milner; Stephen J Kaufman; Hemal H Patel; David M Roth; H Kirk Hammond; Susan S Taylor; Wolfgang H Dillmann; Joshua I Goldhaber; Robert S Ross
Journal:  J Clin Invest       Date:  2013-09-16       Impact factor: 14.808

6.  Limited functional and metabolic improvements in hypertrophic and healthy rat heart overexpressing the skeletal muscle isoform of SERCA1 by adenoviral gene transfer in vivo.

Authors:  J Michael O'Donnell; Aaron Fields; Xianyao Xu; Shamim A K Chowdhury; David L Geenen; Jian Bi
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-10-24       Impact factor: 4.733

7.  Sorcin modulates mitochondrial Ca(2+) handling and reduces apoptosis in neonatal rat cardiac myocytes.

Authors:  Jorge Suarez; Patrick M McDonough; Brian T Scott; Angelica Suarez-Ramirez; Hong Wang; Eduardo S Fricovsky; Wolfgang H Dillmann
Journal:  Am J Physiol Cell Physiol       Date:  2012-11-14       Impact factor: 4.249

8.  Conditional increase in SERCA2a protein is able to reverse contractile dysfunction and abnormal calcium flux in established diabetic cardiomyopathy.

Authors:  Jorge Suarez; Brian Scott; Wolfgang H Dillmann
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-09-17       Impact factor: 3.619

9.  Alterations in mitochondrial function and cytosolic calcium induced by hyperglycemia are restored by mitochondrial transcription factor A in cardiomyocytes.

Authors:  Jorge Suarez; Yong Hu; Ayako Makino; Eduardo Fricovsky; Hong Wang; Wolfgang H Dillmann
Journal:  Am J Physiol Cell Physiol       Date:  2008-10-22       Impact factor: 4.249

10.  Gene remodeling in type 2 diabetic cardiomyopathy and its phenotypic rescue with SERCA2a.

Authors:  Ioannis Karakikes; Maengjo Kim; Lahouaria Hadri; Susumu Sakata; Yezhou Sun; Weijia Zhang; Elie R Chemaly; Roger J Hajjar; Djamel Lebeche
Journal:  PLoS One       Date:  2009-07-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.